Amir Mechria resigns from the Board of Directors of Pharmalys Laboratories SA

21.08.2019 18:30

HOCHDORF Group Press Release: Amir Mechria resigns

Hochdorf, 21 August 2019 – Today, Amir Mechria informed the Board of Directors of Pharmalys Laboratories SA, a subsidiary of HOCHDORF Holding Ltd, of his immediate resignation as member and Vice President of the Board of Directors of Pharmalys Laboratories SA. He will also resign from all other functions within Pharmalys Laboratories SA. The HOCHDORF Group takes note of the resignation of Amir Mechria.

 

Contact:
Dr Christoph Hug, Head of Corporate Communications HOCHDORF Group, Tel:+41 (0)41 914 65 62 / +41 (0)79 859 19 23, christoph.hug@hochdorf.com.

 

About the HOCHDORF Group:
The HOCHDORF Group, based in Hochdorf, achieved a consolidated gross sales revenue of CHF 561.0 million in 2018. It is one of the leading foodstuff companies in Switzerland, employing over 694 staff as of 31.12.2018.Made from natural ingredients such as milk, wheat germ and oil seeds, HOCHDORF products have been contributing to our health and wellbeing since 1895 – from babies to senior citizens. Its customers include the food industry and the wholesale and retail sectors. Its products are sold in over 90 countries. The shares are traded on the SIX Swiss Exchange in Zurich (ISIN CH0024666528).